PERSPECTA

News from every angle

← Back to headlines

CTO, InvenTrust, Regeneron Announce Key Business Updates

CTO outlined its 2026 core FFO and structured investment targets, while InvenTrust also raised its 2026 NAREIT FFO guidance. Separately, Regeneron provided an update on its EYLEA HD prefilled syringe decision and 2026 GAAP gross margin.

29 Apr, 19:03 — 29 Apr, 19:03
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed108d ago

CTO outlines raised 2026 core FFO of $2.06-$2.11 as structured investments target $175M-$250M

Read full article →

Related Stories

Croatian Lottery Player Wins Nearly 160,000 Euros

16h ago

NUPRC Proposes Crude Swap Deals to Boost Nigerian Refinery Supply

1d ago

e-EFKA and DYPA Announce Payment Schedule Until August 21

1d ago

Joshua Kushner's Thrive Capital Invests $215 Million in Amazon

1d ago